Exact Mass: 281.1562

Exact Mass Matches: 281.1562

Found 478 metabolites which its exact mass value is equals to given mass value 281.1562, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cycloheximide

2,6-PIPERIDINEDIONE, 4-(2-(3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-, (1S-(1.ALPHA.(S*),3.ALPHA.,5.BETA.))-

C15H23NO4 (281.1627)


Cycloheximide appears as colorless crystals. Used as a fungicide and as a anticancer drug. (EPA, 1998) Cycloheximide is a dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. It has a role as a bacterial metabolite, a protein synthesis inhibitor, a neuroprotective agent, an anticoronaviral agent and a ferroptosis inhibitor. It is a member of piperidones, a piperidine antibiotic, an antibiotic fungicide, a dicarboximide, a secondary alcohol and a cyclic ketone. It is functionally related to a piperidine-2,6-dione. Cycloheximide is a natural product found in Streptomyces, Streptomyces griseus, and Streptomyces pulveraceus with data available. Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Origin: Microbe; SubCategory_DNP: Alkaloids derived from lysine, Piperidine alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.773 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.776 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.777 [Raw Data] CBA53_Cycloheximid_pos_50eV.txt [Raw Data] CBA53_Cycloheximid_pos_20eV.txt [Raw Data] CBA53_Cycloheximid_pos_10eV.txt [Raw Data] CBA53_Cycloheximid_pos_40eV.txt [Raw Data] CBA53_Cycloheximid_pos_30eV.txt

   

Pendimethalin

N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzenamine

C13H19N3O4 (281.1375)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3116 CONFIDENCE standard compound; INTERNAL_ID 2549 CONFIDENCE standard compound; INTERNAL_ID 4059 CONFIDENCE standard compound; INTERNAL_ID 8435 D010575 - Pesticides > D006540 - Herbicides KEIO_ID P183; [MS2] KO009157 KEIO_ID P183; [MS3] KO009158 D016573 - Agrochemicals KEIO_ID P183

   

1-Methyladenosine

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


1-Methyladenosine, also known as M1A, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Precise m6A mapping by m6A-CLIP/IP (briefly m6A-CLIP) revealed that a majority of m6A locates in the last exon of mRNAs in multiple tissues/cultured cells of mouse and human, and the m6A enrichment around stop codons is a coincidence that many stop codons locate round the start of last exons where m6A is truly enriched. The methylation of adenosine is directed by a large m6A methyltransferase complex containing METTL3 as the SAM-binding sub-unit. Insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1-3) are reported as a novel class of m6A readers. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

NSC100044

O(6)-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


O6-Methyldeoxy guanosine; DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

Harzianopyridone

Harzianopyridone

C14H19NO5 (281.1263)


   

Xanomeline tartrate

5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine

C14H23N3OS (281.1562)


Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

Triphenylcyanoethylene

2,3,3-Triphenylacrylonitrile; Triphenylcyanoethylene

C21H15N (281.1204)


   

Diminazene

4-[(2E)-3-(4-carbamimidoylphenyl)triaz-2-en-1-yl]benzene-1-carboximidamide

C14H15N7 (281.1389)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

colestipol

Tetraethylenepentamine crosslinked with epichlorohydrin

C11H28ClN5O (281.1982)


It is used as a food additive . C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AC - Bile acid sequestrants D019995 - Laboratory Chemicals > D007475 - Ion Exchange Resins > D000837 - Anion Exchange Resins D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D001697 - Biomedical and Dental Materials D064449 - Sequestering Agents

   

XANOMELINE

XANOMELINE

C14H23N3OS (281.1562)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

phentolamine

phentolamine

C17H19N3O (281.1528)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

Floribundine

16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


Floribundine is an isoquinoline alkaloid. Floribundine is a natural product found in Annona purpurea, Tephroseris palustris, and other organisms with data available. Alkaloid from Nelumbo nucifera (East India lotus). Floribundine is found in tea, cherimoya, and coffee and coffee products. Floribundine is found in cherimoya. Floribundine is an alkaloid from Nelumbo nucifera (East India lotus

   

2'-O-Methyladenosine

5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


2-O-Methyladenosine is a methylated adenine residue. 2-O-Methyladenosine is a naturally occurring 2-O-methylpurine nucleoside with long lasting hypotensive properties; resistance of 2-O-methyladenosine against adenosine deaminase is thought to contribute to prolonged activity. 2-O-Methyladenosine occurs in human fluids, and they increase in urines of untreated adenosine deaminase (ADA) deficient patients (OMIM 608958). (PMID: 9539952, 6980397) [HMDB] 2-O-Methyladenosine is a methylated adenine residue. 2-O-Methyladenosine is a naturally occurring 2-O-methylpurine nucleoside with long lasting hypotensive properties; resistance of 2-O-methyladenosine against adenosine deaminase is thought to contribute to prolonged activity. 2-O-Methyladenosine occurs in human fluids, and they increase in urines of untreated adenosine deaminase (ADA) deficient patients (OMIM 608958). (PMID: 9539952, 6980397). 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2]. 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2].

   

Phentolamine

3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol

C17H19N3O (281.1528)


Phentolamine is only found in individuals that have used or taken this drug. It is a nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease (PubChem). Phentolamine produces its therapeutic actions by competitively blocking alpha-adrenergic receptors (primarily excitatory responses of smooth muscle and exocrine glands), leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. The action of phentolamine on the alpha adrenergic receptors is relatively transient and the blocking effect is incomplete. The drug is more effective in antagonizing responses to circulating epinephrine and/or norepinephrine than in antagonizing responses to mediator released at the adrenergic nerve ending. Phentolamine also stimulates β-adrenergic receptors and produces a positive inotropic and chronotropic effect on the heart and increases cardiac output. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

8-hydroxymirtazapine

5-methyl-2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(19),8,10,12,15,17-hexaen-17-ol

C17H19N3O (281.1528)


8-hydroxymirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

N6-Methyladenosine

(2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3,4-diol

C11H15N5O4 (281.1124)


N6-Methyladenosine is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820) [HMDB] N6-Methyladenosine is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820). N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

3'-O-Methyladenosine

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


3-O-Methyladenosine is a methylated adenine residue. [HMDB] 3-O-Methyladenosine is a methylated adenine residue. (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol (Adenosine, 3'-O-methyl- (8CI)(9CI)) is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

Diphenylpyraline

1-Methyl-4-hydroxypiperidine benzhydryl ether

C19H23NO (281.178)


Diphenylpyraline is an antihistamine. Antihistamines used in the treatment of allergy act by competing with histamine for H 1-receptor sites on effector cells. Antihistamines prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline is a potent histamine H1?receptor antagonist. Diphenylpyraline acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline can be used for the research of allergic diseases, including rhinitis and hay fever, and pruritic skin disorders et.al[1].

   

N-(1-Deoxy-1-fructosyl)threonine

(2S)-3-hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)butanoic acid

C10H19NO8 (281.1111)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)threonine is classified as a Natural Food Constituent (code WA) in the DFC.

   

(E)-2-Hydroxy-N-desmethyldoxepin

(2E)-2-[3-(methylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-ol

C18H19NO2 (281.1416)


(E)-2-Hydroxy-N-desmethyldoxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)

   

mirtazapine-N-oxide

5-methyl-2,5λ⁵,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaen-5-one

C17H19N3O (281.1528)


mirtazapine-N-oxide is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one

1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one

C19H23NO (281.178)


   

1-Methyladenosin

2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

11-Maleimidoundecanoic acid

11-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)undecanoic acid

C15H23NO4 (281.1627)


   

(S)-3-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine

(S)-3-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine hydrochloride

C15H23NO2S (281.1449)


   

4-(4-Fluoronaphthalen-1-yl)-6-isopropylpyrimidin-2-amine

4-(4-fluoronaphthalen-1-yl)-6-(propan-2-yl)pyrimidin-2-amine

C17H16FN3 (281.1328)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

7-phenyl-7-(pyridin-4-yl)hept-6-enoic acid

C18H19NO2 (281.1416)


   

Caffeine, 8-((3-methoxypropyl)amino)-

8-[(3-methoxypropyl)amino]-1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C12H19N5O3 (281.1488)


   

Apocodeine

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaen-3-ol

C18H19NO2 (281.1416)


   

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)propanoic acid

C15H23NO4 (281.1627)


   

Cycloheximide

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

Isbogrel

7-phenyl-7-(pyridin-3-yl)hept-6-enoic acid

C18H19NO2 (281.1416)


   

Isoapocodeine

3-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaen-4-ol

C18H19NO2 (281.1416)


   

Lufironil

N2,N4-bis(2-methoxyethyl)pyridine-2,4-dicarboxamide

C13H19N3O4 (281.1375)


C471 - Enzyme Inhibitor

   

N-Nornuciferine

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

L-3-(3-Hydroxy-4-pivaloyloxyphenyl)alanine

2-amino-3-{4-[(2,2-dimethylpropanoyl)oxy]-3-hydroxyphenyl}propanoic acid

C14H19NO5 (281.1263)


   

Northiaden

methyl(3-{9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine

C18H19NS (281.1238)


   

O(6)-Methyl-2'-deoxyguanosine

5-(2-amino-6-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C11H15N5O4 (281.1124)


   

Piberaline

1-benzyl-4-(pyridine-2-carbonyl)piperazine

C17H19N3O (281.1528)


   

Pridopidine

4-(3-Methanesulphonylphenyl)-1-propylpiperidine

C15H23NO2S (281.1449)


C78272 - Agent Affecting Nervous System Pridopidine, a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist. Pridopidine exerts high affinity towards sigma 1 receptor (S1R) with Ki between 70 and 80 nM, which is ~100× higher than its affinity toward D2R.

   

N-(2-(Mercaptomethyl)-3-phenylbutanoyl)-L-alanine

2-{[1-hydroxy-3-phenyl-2-(sulphanylmethyl)butylidene]amino}propanoic acid

C14H19NO3S (281.1086)


   

Sanfetrinem

1-(1-hydroxyethyl)-5-methoxy-2-oxo-1H,2H,5H,6H,7H,8H,8aH,8bH-azeto[2,1-a]isoindole-4-carboxylic acid

C14H19NO5 (281.1263)


   

4-Methyl-3-[4-(4-oxopyridin-1-yl)phenyl]-4,5-dihydro-1H-pyridazin-6-one

5-methyl-6-[4-(4-oxo-1,4-dihydropyridin-1-yl)phenyl]-2,3,4,5-tetrahydropyridazin-3-one

C16H15N3O2 (281.1164)


   

dihydroxyphaseic acid

5-{3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl}-3-methylpenta-2,4-dienoic acid

C15H21O5 (281.1389)


Dihydroxyphaseic acid is also known as dihydroxyphaseate. Dihydroxyphaseic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Dihydroxyphaseic acid can be found in a number of food items such as olive, turmeric, macadamia nut, and shiitake, which makes dihydroxyphaseic acid a potential biomarker for the consumption of these food products.

   

1-Methyladenosine

1-Methyladenosine

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

Euchrestine A

Euchrestine A

C18H19NO2 (281.1416)


   
   

Mortivinacin C

Mortivinacin C

C14H19NO5 (281.1263)


   

2-Methoxyaporphin-1-ol

2-Methoxyaporphin-1-ol

C18H19NO2 (281.1416)


   

Nornuciferine

Nornuciferine

C18H19NO2 (281.1416)


   

MCULE-5769297339

MCULE-5769297339

C15H23NO4 (281.1627)


   
   

CJ 13565

(E)-2-(3,7-Dimethyl-2,6-octadienyl)-4(1H)-quinolinone

C19H23NO (281.178)


   

Haplacutine D

Haplacutine D

C18H19NO2 (281.1416)


   

naphyrone

naphyrone

C19H23NO (281.178)


   
   

3-(2-ethyl-5-methylpyrazol-3-yl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(2-ethyl-5-methylpyrazol-3-yl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C12H19N5OS (281.131)


   

N-[(2,2-dimethylpropanoyl)oxy]-6-(ethylthio)pyridine-3-carboximidamide

N-[(2,2-dimethylpropanoyl)oxy]-6-(ethylthio)pyridine-3-carboximidamide

C13H19N3O2S (281.1198)


   

Diethyl 2-[(4-fluoroanilino)methylene]malonate

Diethyl 2-[(4-fluoroanilino)methylene]malonate

C14H16FNO4 (281.1063)


   

Maybridge1_002040

Maybridge1_002040

C14H19NO3S (281.1086)


   

SCHEMBL154292

SCHEMBL154292

C18H19NO2 (281.1416)


   

2-Methyladenosine

2-Methyladenosine

C11H15N5O4 (281.1124)


   

Coumarin 106

Coumarin 106

C18H19NO2 (281.1416)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.416 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.417

   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   
   

(E,E,E)-2,4,12-Tetradecatriene-8,10-diynoic acid piperidide

(E,E,E)-2,4,12-Tetradecatriene-8,10-diynoic acid piperidide

C19H23NO (281.178)


   

7-Alcohol-Spirostaphylotrichin F|spirostaphylotrichin L

7-Alcohol-Spirostaphylotrichin F|spirostaphylotrichin L

C14H19NO5 (281.1263)


   

6beta-Acetoxy-3alpha-tigloyloxytropane

6beta-Acetoxy-3alpha-tigloyloxytropane

C15H23NO4 (281.1627)


   

Me glycoside,4,6-O-benzylidene-alpha-D-Pyranose-3-Amino-3-deoxyglucose

Me glycoside,4,6-O-benzylidene-alpha-D-Pyranose-3-Amino-3-deoxyglucose

C14H19NO5 (281.1263)


   

(2E,4E,6E,12Z)-3-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

(2E,4E,6E,12Z)-3-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

C19H23NO (281.178)


   

dictylomide A|Dictyolomide A

dictylomide A|Dictyolomide A

C19H23NO (281.178)


   

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin|Euglenapterin

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin|Euglenapterin

C11H15N5O4 (281.1124)


   

Methyl b-neuraminic acid

Methyl b-neuraminic acid

C10H19NO8 (281.1111)


   
   

scalusamide B

scalusamide B

C16H27NO3 (281.1991)


   

Spirostaphylotrichin T

Spirostaphylotrichin T

C14H19NO5 (281.1263)


   

CHEMBL1192721

CHEMBL1192721

C15H23NO4 (281.1627)


   

SCHEMBL15338502

SCHEMBL15338502

C11H15N5O4 (281.1124)


   

AKOS017074913

AKOS017074913

C18H19NO2 (281.1416)


   

Deacetyllycofawcine

Deacetyllycofawcine

C16H27NO3 (281.1991)


   

SCHEMBL9735646

SCHEMBL9735646

C18H19NO2 (281.1416)


   

penibruguieramine A

penibruguieramine A

C16H27NO3 (281.1991)


   

scalusamide A

scalusamide A

C16H27NO3 (281.1991)


A pyrrolidine alkaloid that is a monocarboxylic acid amide obtained by the formal condensation of (8E)-2-methyl-3-oxodec-8-enoic acid with (2R)-pyrrolidin-2-ylmethanol. Isolated from the the cultured broth of the fungus Penicillium citrinum, it exhibits anti-fungal and antibacterial activity.

   

(S)-benzhydryl 3,3-dimethylaziridine-2-carboxylate|benzhydryl (S)-3,3-dimethylaziridine-2-carboxylate

(S)-benzhydryl 3,3-dimethylaziridine-2-carboxylate|benzhydryl (S)-3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

(+)-Dicrotaline

(+)-Dicrotaline

C14H19NO5 (281.1263)


   

(+)-Isoboldine

(+)-Isoboldine

C18H19NO2 (281.1416)


   

Curcutriolamide

Curcutriolamide

C15H23NO4 (281.1627)


   

5,6,6a,7-Tetrahydro-6-methyl-10-methoxy-4H-dibenzo[de,g]quinolin-9-ol

5,6,6a,7-Tetrahydro-6-methyl-10-methoxy-4H-dibenzo[de,g]quinolin-9-ol

C18H19NO2 (281.1416)


   

1-(dibenzylamino) cyclopropanecarboxylic acid

1-(dibenzylamino) cyclopropanecarboxylic acid

C18H19NO2 (281.1416)


   

SCHEMBL17866868

SCHEMBL17866868

C19H23NO (281.178)


   

Spirostaphylotrichin O

Spirostaphylotrichin O

C14H19NO5 (281.1263)


   

Me ether-(??)-Peyoruvic acid

Me ether-(??)-Peyoruvic acid

C14H19NO5 (281.1263)


   

N-(1-deoxy-D-fructos-1-yl)-L-threonine|N-(1-Desoxy-D-fructos-1-yl)-L-threonin|N-D-Fructose-1-yl-LS-threonin|N-D-fructose-1-yl-LS-threonine

N-(1-deoxy-D-fructos-1-yl)-L-threonine|N-(1-Desoxy-D-fructos-1-yl)-L-threonin|N-D-Fructose-1-yl-LS-threonin|N-D-fructose-1-yl-LS-threonine

C10H19NO8 (281.1111)


   

Sanjoinine Ia

(9R)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


N-Nornuciferine is a natural product found in Meiogyne monosperma, Neolitsea konishii, and other organisms with data available. N-Nornuciferine is an aporphine alkaloid in lotus leaf that significantly inhibits CYP2D6 with IC50 and Ki of 3.76 and 2.34 μM, respectively. N-Nornuciferine is an aporphine alkaloid in lotus leaf that significantly inhibits CYP2D6 with IC50 and Ki of 3.76 and 2.34 μM, respectively.

   

Lirinidine

4H-Dibenzo(de,g)quinolin-1-ol, 5,6,6a,7-tetrahydro-2-methoxy-6-methyl-, (S)-

C18H19NO2 (281.1416)


Lirinidine is a natural product found in Annona purpurea, Ocotea macrophylla, and other organisms with data available. Lirinidine ((+)-Lirinidine) is an alkaloid isolated from the leaves of?L. tulipifera and has antioxidant and anticancer?activities. Lirinidine exhibits medium ferric reducing power activity and minor radical scavenging activity in vitro. Lirinidine can be used for cosmetic research[1]. Lirinidine ((+)-Lirinidine) is an alkaloid isolated from the leaves of?L. tulipifera and has antioxidant and anticancer?activities. Lirinidine exhibits medium ferric reducing power activity and minor radical scavenging activity in vitro. Lirinidine can be used for cosmetic research[1].

   

Calgam

(2R,3S,4R,5R)-6-[2-(dimethylamino)acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

C10H19NO8 (281.1111)


   

Methylasimilobine

4H-Dibenzo[de,g]quinolin-2-ol, 5,6,6a,7-tetrahydro-1-methoxy-6-methyl-, (6aR)-

C18H19NO2 (281.1416)


O-Nornuciferine is a natural product found in Annona purpurea, Stephania cephalantha, and other organisms with data available.

   

8-Hydroxymirtazapine

8-hydroxy Mirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3712 CONFIDENCE standard compound; INTERNAL_ID 1555

   

10b-Methyl-3,4,5,6,10b,11-hexahydro-2H-4b-aza-chrysene-1,12-dione

"NCGC00160261-01!10b-Methyl-3,4,5,6,10b,11-hexahydro-2H-4b-aza-chrysene-1,12-dione"

C18H19NO2 (281.1416)


   

MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

"MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione"

C15H23NO4 (281.1627)


   

1-Methyladenosine

1-Methyladenosine

C11H15N5O4 (281.1124)


A methyladenosine carrying a methyl substituent at position 1. CONFIDENCE standard compound; INTERNAL_ID 313 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   

2-O-methyladenosine

5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


CONFIDENCE standard compound; INTERNAL_ID 312 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2]. 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities [1][2].

   

6-Methyladenosine

6-methylamino-9-beta-delta-Ribofuranosyl-purine

C11H15N5O4 (281.1124)


N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

2-O-Methyladenosine

2-O-Methyladenosine

C11H15N5O4 (281.1124)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 5

   

N6-Methyladenosine

N6-Methyladenosine

C11H15N5O4 (281.1124)


CONFIDENCE standard compound; INTERNAL_ID 307 N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.

   

Isocycloheximide

Isocycloheximide

C15H23NO4 (281.1627)


   
   

L-METHYLADENOSINE

L-METHYLADENOSINE

C11H15N5O4 (281.1124)


1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. 1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents.

   

8-OH-Mirtazapine

8-Hydroxymirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; INTERNAL_ID 1555

   

N-Methylasimilobine

N-Methylasimilobine

C18H19NO2 (281.1416)


   

Dainic Acid A

Dainic Acid A

C15H23NO4 (281.1627)


An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a (2E)-6-methylhepta-2,5-dien-2-yl group at position 4. It is produced by the red algal Chondria armata.

   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based on: CCMSLIB00000846613]

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based on: CCMSLIB00000846613]

C16H27NO3 (281.1991)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

C15H23NO4 (281.1627)


   

12,13-Dehydroprolyltryptophanyldiketopiperazine

12,13-Dehydroprolyltryptophanyldiketopiperazine

C16H15N3O2 (281.1164)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

C15H23NO4 (281.1627)


   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based: Match]

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based: Match]

C16H27NO3 (281.1991)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

C15H23NO4 (281.1627)


   

N6-Me-Adenosine

N6-Me-Adenosine

C11H15N5O4 (281.1124)


consensus spectrum

   

N1-Methyladenosine; LC-tDDA; CE10

N1-Methyladenosine; LC-tDDA; CE10

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE20

N1-Methyladenosine; LC-tDDA; CE20

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE30

N1-Methyladenosine; LC-tDDA; CE30

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE10

1-Methyldesoxyguanosine; LC-tDDA; CE10

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE20

1-Methyldesoxyguanosine; LC-tDDA; CE20

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE30

1-Methyldesoxyguanosine; LC-tDDA; CE30

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; LC-tDDA; CE40

1-Methyldesoxyguanosine; LC-tDDA; CE40

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE0; CorrDec

N1-Methyladenosine; AIF; CE0; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE10; CorrDec

N1-Methyladenosine; AIF; CE10; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE30; CorrDec

N1-Methyladenosine; AIF; CE30; CorrDec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE0; MS2Dec

N1-Methyladenosine; AIF; CE0; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE30; MS2Dec

N1-Methyladenosine; AIF; CE30; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; AIF; CE10; MS2Dec

N1-Methyladenosine; AIF; CE10; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE0; CorrDec

1-Methyldesoxyguanosine; AIF; CE0; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE10; CorrDec

1-Methyldesoxyguanosine; AIF; CE10; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE0; MS2Dec

1-Methyldesoxyguanosine; AIF; CE0; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE30; CorrDec

1-Methyldesoxyguanosine; AIF; CE30; CorrDec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE10; MS2Dec

1-Methyldesoxyguanosine; AIF; CE10; MS2Dec

C11H15N5O4 (281.1124)


   

1-Methyldesoxyguanosine; AIF; CE30; MS2Dec

1-Methyldesoxyguanosine; AIF; CE30; MS2Dec

C11H15N5O4 (281.1124)


   

N1-Methyladenosine; LC-tDDA; CE40

N1-Methyladenosine; LC-tDDA; CE40

C11H15N5O4 (281.1124)


   

O6-Methyl-deoxyguanosine

O6-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

N2-Methyl-deoxyguanosine

N2-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

1-Methyl-deoxyguanosine

1-Methyl-deoxyguanosine

C11H15N5O4 (281.1124)


   

N6-Methyl-adenosine

N6-Methyl-adenosine

C11H15N5O4 (281.1124)


   

Pangamic Acid_major

Pangamic Acid_major

C10H19NO8 (281.1111)


   

4-Hydroxyoxprenolol

4-Hydroxyoxprenolol

C15H23NO4 (281.1627)


   

Northiadene

Northiadene

C18H19NS (281.1238)


   

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

C15H23NO4 (281.1627)


   

3-O-Methyladenosine

Adenosine, 3-O-methyl-(7CI,8CI,9CI)

C11H15N5O4 (281.1124)


(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol (Adenosine, 3'-O-methyl- (8CI)(9CI)) is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].

   

diphenylpyraline

Diphenylpyralamine;Diphenylpyraline Hydrochloride;Diphenylpyrilene

C19H23NO (281.178)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline is a potent histamine H1?receptor antagonist. Diphenylpyraline acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline can be used for the research of allergic diseases, including rhinitis and hay fever, and pruritic skin disorders et.al[1].

   

Floribundine

16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

Naphyrone 1-naphthyl isomer

Naphyrone 1-naphthyl isomer

C19H23NO (281.178)


   

N-octanoyl histidine

N-octanoyl-histidine

C14H23N3O3 (281.1739)


   

C12:1-HSL

N-(2E-dodecenoyl)-homoserine lactone

C16H27NO3 (281.1991)


   

5-cis-C12-HSL

N-(5Z-dodecenoyl)-homoserine lactone

C16H27NO3 (281.1991)


   

1,4,5,7-Tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl 3-methyl ester

1,4,5,7-Tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl 3-methyl ester

C13H19N3O4 (281.1375)


   

N-(5-pyridin-3-yl-2H-pyrazolo[3,4-b]pyridin-3-yl)butanamide

N-(5-pyridin-3-yl-2H-pyrazolo[3,4-b]pyridin-3-yl)butanamide

C15H15N5O (281.1277)


   

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

C15H23NO4 (281.1627)


   
   

8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-, benzoate (ester), hydrochloride, (3-exo)- (9CI)

8-Azabicyclo[3.2.1]octan-3-ol,8-methyl-, benzoate (ester), hydrochloride, (3-exo)- (9CI)

C15H20ClNO2 (281.1182)


   

TERT-BUTYL 4-(METHOXYCARBONYL)-3-METHOXYPHENYLCARBAMATE

TERT-BUTYL 4-(METHOXYCARBONYL)-3-METHOXYPHENYLCARBAMATE

C14H19NO5 (281.1263)


   

methyl 2-(2-benzyl-1,3-dihydroisoindol-1-yl)acetate

methyl 2-(2-benzyl-1,3-dihydroisoindol-1-yl)acetate

C18H19NO2 (281.1416)


   

dioxosilane,3-triethoxysilylpropan-1-amine

dioxosilane,3-triethoxysilylpropan-1-amine

C9H23NO5Si2 (281.1115)


   

N-Desmethyl Sumatriptan

N-Desmethyl Sumatriptan

C13H19N3O2S (281.1198)


   

(R)-2-N-CBZ-AMINO-PENTANE-1,5-DIOL

(R)-2-N-CBZ-AMINO-PENTANE-1,5-DIOL

C14H19NO5 (281.1263)


   

5-(BENZYLOXY)-1H-INDOLE-2-CARBOHYDRAZIDE

5-(BENZYLOXY)-1H-INDOLE-2-CARBOHYDRAZIDE

C16H15N3O2 (281.1164)


   

(3-AMINOSULPHONYL)BENZENEBORONICACID

(3-AMINOSULPHONYL)BENZENEBORONICACID

C16H15N3O2 (281.1164)


   

Piberaline

Piberaline

C17H19N3O (281.1528)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

4-[(1-methylbenzimidazol-2-yl)methylamino]benzoic acid

4-[(1-methylbenzimidazol-2-yl)methylamino]benzoic acid

C16H15N3O2 (281.1164)


   

4-(PIPERAZIN-1-YL)-2-(TRIFLUOROMETHYL)QUINOLINE

4-(PIPERAZIN-1-YL)-2-(TRIFLUOROMETHYL)QUINOLINE

C14H14F3N3 (281.114)


   

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C15H23NO4 (281.1627)


   

(S)-(-)-4-isopropyl-5,5-diphenyl-2-oxazolidinone

(S)-(-)-4-isopropyl-5,5-diphenyl-2-oxazolidinone

C18H19NO2 (281.1416)


   

4-tert-Butylamino-6-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

4-tert-Butylamino-6-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

C12H19N5O3 (281.1488)


   

ANTHRANILICACID,N-BOC-N-METHYL-5-METHOXY

ANTHRANILICACID,N-BOC-N-METHYL-5-METHOXY

C14H19NO5 (281.1263)


   

1-(1-tert-Butoxycarbonyl-pyrrolidin-3-yl)-1H-imidazole-4-carboxylic acid

1-(1-tert-Butoxycarbonyl-pyrrolidin-3-yl)-1H-imidazole-4-carboxylic acid

C13H19N3O4 (281.1375)


   

Pyrovalerone hydrochloride solution

Pyrovalerone hydrochloride solution

C16H24ClNO (281.1546)


   

3-methoxy-3,3-diphenyl-N-prop-2-enylpropan-1-amine

3-methoxy-3,3-diphenyl-N-prop-2-enylpropan-1-amine

C19H23NO (281.178)


   

1,4-dibenzylpiperidin-4-ol

1,4-dibenzylpiperidin-4-ol

C19H23NO (281.178)


   
   

Boc-(R)-3-amino-3-(4-hydroxy-phenyl)- propionic acid

Boc-(R)-3-amino-3-(4-hydroxy-phenyl)- propionic acid

C14H19NO5 (281.1263)


   

(4-HYDROXY-[1,1-BIPHENYL]-4-YL)(PIPERIDIN-1-YL)METHANONE

(4-HYDROXY-[1,1-BIPHENYL]-4-YL)(PIPERIDIN-1-YL)METHANONE

C18H19NO2 (281.1416)


   

1-(boc-amino)-1-(4-chlorophenyl)-cyclobutane

1-(boc-amino)-1-(4-chlorophenyl)-cyclobutane

C15H20ClNO2 (281.1182)


   

tert-butyl N-[2-amino-2-(2-nitrophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(2-nitrophenyl)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Boc-R-3-OH-PHA

Boc-R-3-OH-PHA

C14H19NO5 (281.1263)


   

2,2,3,4,5,5-HEXAMETHYL-3-IMIDAZOLINIUM-1-YLOXY METHYL SULFATE

2,2,3,4,5,5-HEXAMETHYL-3-IMIDAZOLINIUM-1-YLOXY METHYL SULFATE

C10H21N2O5S (281.1171)


   

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

C17H20BNO2 (281.1587)


   

acetic acid; 2-[(2-aminoacetyl)amino]-3-phenyl-propanamide

acetic acid; 2-[(2-aminoacetyl)amino]-3-phenyl-propanamide

C13H19N3O4 (281.1375)


   

4-(4-BENZYLPIPERAZIN-1-YLMETHYL)PHENYLAMINE

4-(4-BENZYLPIPERAZIN-1-YLMETHYL)PHENYLAMINE

C18H23N3 (281.1892)


   

trimetozine

trimetozine

C14H19NO5 (281.1263)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

(2S,4S)-1-BENZYL-2-METHY-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

(2S,4S)-1-BENZYL-2-METHY-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

C14H16FNO4 (281.1063)


   

2-[4-(dimethylamino)phenyl]-3H-benzimidazole-5-carboxylic acid

2-[4-(dimethylamino)phenyl]-3H-benzimidazole-5-carboxylic acid

C16H15N3O2 (281.1164)


   

Benzyl 4-[Methoxy(Methyl)aMino]-4-oxobutanoate

Benzyl 4-[Methoxy(Methyl)aMino]-4-oxobutanoate

C14H16FNO4 (281.1063)


   

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   

2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)-N-phenylacetamide

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-PHENYL-ACETAMIDE

C16H15N3O2 (281.1164)


   

(1S,3S,5S)-2-Azabicyclo[3,3,0]octane-3-carborylic acid benzyl ester hydrochloride

(1S,3S,5S)-2-Azabicyclo[3,3,0]octane-3-carborylic acid benzyl ester hydrochloride

C15H20ClNO2 (281.1182)


   

(S)-Ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

(S)-Ethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

C18H19NO2 (281.1416)


   

N,N-DIPROPYL-2,6-DINITRO-PARA-TOLUIDINE

N,N-DIPROPYL-2,6-DINITRO-PARA-TOLUIDINE

C13H19N3O4 (281.1375)


   

TERT-BUTYL (4-IODO-5-METHOXYPYRIDIN-3-YL)-METHYLCARBAMATE

TERT-BUTYL (4-IODO-5-METHOXYPYRIDIN-3-YL)-METHYLCARBAMATE

C13H19N3O4 (281.1375)


   

2-Phenylpyridine-4-boronic acid pinacol ester

2-Phenylpyridine-4-boronic acid pinacol ester

C17H20BNO2 (281.1587)


   

Boc-(S)-3-Amino-3-(2-hydroxy-phenyl)-propionic acid

Boc-(S)-3-Amino-3-(2-hydroxy-phenyl)-propionic acid

C14H19NO5 (281.1263)


   

tert-butyl (3R)-3-(4-fluorophenoxy)pyrrolidine-1-carboxylate

tert-butyl (3R)-3-(4-fluorophenoxy)pyrrolidine-1-carboxylate

C15H20FNO3 (281.1427)


   

Boc-Ser(Bzl)-ol

Boc-Ser(Bzl)-ol

C15H23NO4 (281.1627)


   
   

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

C17H19N3O (281.1528)


   

4-(benzhydryloxymethyl)piperidine

4-(benzhydryloxymethyl)piperidine

C19H23NO (281.178)


   

1-[(Benzyloxy)carbonyl]-3-fluoro-3-piperidinecarboxylic acid

1-[(Benzyloxy)carbonyl]-3-fluoro-3-piperidinecarboxylic acid

C14H16FNO4 (281.1063)


   

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

C17H19N3O (281.1528)


   

di-beta-d-xylopyranosylamine

di-beta-d-xylopyranosylamine

C10H19NO8 (281.1111)


   

Methyl 1-benzhydrylazetidine-3-carboxylate

Methyl 1-benzhydrylazetidine-3-carboxylate

C18H19NO2 (281.1416)


   

3-benzyl-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

3-benzyl-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

C18H19NO2 (281.1416)


   

N-Boc-3-hydroxy-L-phenylalanine

N-Boc-3-hydroxy-L-phenylalanine

C14H19NO5 (281.1263)


   

2-(4-DIMETHYLAMINO-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID

2-(4-DIMETHYLAMINO-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID

C16H15N3O2 (281.1164)


   

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)-1,4-diazepane-1-carboxylate

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)-1,4-diazepane-1-carboxylate

C13H23N5O2 (281.1852)


   

2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]pyridine-3-carboxylic acid

2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]pyridine-3-carboxylic acid

C13H19N3O4 (281.1375)


   

H-Asp(OBut)-ObutHCL

H-Asp(OBut)-ObutHCL

C12H24ClNO4 (281.1394)


   

(3-CHLORO-PYRIDIN-2-YL)-METHYL AMINE DIHYDROCHLORIDE

(3-CHLORO-PYRIDIN-2-YL)-METHYL AMINE DIHYDROCHLORIDE

C18H19NO2 (281.1416)


   

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

C16H24ClNO (281.1546)


   

4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHOXY)BENZOIC ACID

4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHOXY)BENZOIC ACID

C14H19NO5 (281.1263)


   

Roxadimate

ethyl 4-[bis(2-hydroxypropyl)amino]benzoate

C15H23NO4 (281.1627)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

Potassium guaiacolsulfonate hemihydrate

Potassium guaiacolsulfonate hemihydrate

C7H8O5S.1/2H2O.K (281.14)


   

Boc-D-threo-3-phenylserine

Boc-D-threo-3-phenylserine

C14H19NO5 (281.1263)


   

11-Maleimidoundecanoic acid

11-Maleimidoundecanoic acid

C15H23NO4 (281.1627)


   

1-Benzyl-4-Phenyl-Pyrrolidine-3-Carboxylic Acid

1-Benzyl-4-Phenyl-Pyrrolidine-3-Carboxylic Acid

C18H19NO2 (281.1416)


   

(s)-boc-beta-tyr-oh

(s)-boc-beta-tyr-oh

C14H19NO5 (281.1263)


   

Lin28-IN-1632

Lin28-IN-1632

C15H15N5O (281.1277)


   

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

C15H23NO4 (281.1627)


   
   

1H-Pyrrole-2-propanoicacid, 4-(ethoxycarbonyl)-3,5-dimethyl-b-oxo-, ethyl ester

1H-Pyrrole-2-propanoicacid, 4-(ethoxycarbonyl)-3,5-dimethyl-b-oxo-, ethyl ester

C14H19NO5 (281.1263)


   

tert-butyl 3-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate

tert-butyl 3-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate

C12H18F3NO3 (281.1239)


   

tert-Butyl 4-(2,2,2-trifluoro-acetyl)piperidin-1-carboxylate

tert-Butyl 4-(2,2,2-trifluoro-acetyl)piperidin-1-carboxylate

C12H18F3NO3 (281.1239)


   

DIETHYL 2-[[(1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]METHYLIDENE]MALONATE

DIETHYL 2-[[(1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]METHYLIDENE]MALONATE

C13H19N3O4 (281.1375)


   

4-(4-Pyridinyl)phenylboronic acid pinacol ester

4-(4-Pyridinyl)phenylboronic acid pinacol ester

C17H20BNO2 (281.1587)


   

3,3-DIMETHYL-1-TOSYLPIPERIDIN-4-ONE

3,3-DIMETHYL-1-TOSYLPIPERIDIN-4-ONE

C14H19NO3S (281.1086)


   

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

C17H20BNO2 (281.1587)


   

DIETHYL 4-ETHYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLATE

DIETHYL 4-ETHYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLATE

C15H23NO4 (281.1627)


   

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one,hydrochloride

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one,hydrochloride

C15H20ClNO2 (281.1182)


   

ethyl 4-(2-methylimidazo[4,5-c]pyridin-1-yl)benzoate

ethyl 4-(2-methylimidazo[4,5-c]pyridin-1-yl)benzoate

C16H15N3O2 (281.1164)


   

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enenitrile

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enenitrile

C15H23NO4 (281.1627)


   

cinnamedrine

cinnamedrine

C19H23NO (281.178)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

(2S,4R)-1-BENZYL-2-METHYL-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

(2S,4R)-1-BENZYL-2-METHYL-4-FLUOROPYRROLIDINE-1,2-DICARBOXYLATE

C14H16FNO4 (281.1063)


   

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

C17H19N3O (281.1528)


   

2-(1-benzyl-3-phenylpyrrolidin-3-yl)ethanol

2-(1-benzyl-3-phenylpyrrolidin-3-yl)ethanol

C19H23NO (281.178)


   

tert-butyl N-[2-amino-2-(4-nitrophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(4-nitrophenyl)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Tolperisone hydrochloride

Tolperisone hydrochloride

C16H24ClNO (281.1546)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant D002491 - Central Nervous System Agents

   

(2R,3S)-Boc-3-Phenylisoserine

(2R,3S)-Boc-3-Phenylisoserine

C14H19NO5 (281.1263)


   
   

2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl-3-carboxylic acid n-hydroxysuccinimide ester

2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl-3-carboxylic acid n-hydroxysuccinimide ester

C13H17N2O5 (281.1137)


   

TERT-BUTOXYCARBONYLAMINO-(2-METHOXY-PHENYL)-ACETIC ACID

TERT-BUTOXYCARBONYLAMINO-(2-METHOXY-PHENYL)-ACETIC ACID

C14H19NO5 (281.1263)


   

Ofornine

piperidin-1-yl-[2-(pyridin-4-ylamino)phenyl]methanone

C17H19N3O (281.1528)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

   
   

boc-o-benzyl-l-serinol

boc-o-benzyl-l-serinol

C15H23NO4 (281.1627)


   

Bis(4-methylphenyl)[(2S)-2-pyrrolidinyl]methanol

Bis(4-methylphenyl)[(2S)-2-pyrrolidinyl]methanol

C19H23NO (281.178)


   

5-Tert-Butyl3-Ethyl4,6-Dihydropyrrolo[3,4-C]Pyrazole-3,5(1H)-Dicarboxylate

5-Tert-Butyl3-Ethyl4,6-Dihydropyrrolo[3,4-C]Pyrazole-3,5(1H)-Dicarboxylate

C13H19N3O4 (281.1375)


   

5-Formyl-3-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(1,1-dimethylethyl) 4-ethyl ester

5-Formyl-3-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(1,1-dimethylethyl) 4-ethyl ester

C14H19NO5 (281.1263)


   

2-((tert-butoxycarbonyl)amino)-2-(4-methoxyphenyl)acetic acid

2-((tert-butoxycarbonyl)amino)-2-(4-methoxyphenyl)acetic acid

C14H19NO5 (281.1263)


   

TRIETHANOLAMINE ETHOXYLATE

TRIETHANOLAMINE ETHOXYLATE

C12H27NO6 (281.1838)


   

Amino-PEG6-alcohol

Amino-PEG6-alcohol

C12H27NO6 (281.1838)


   

3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE

3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE

C18H16FNO (281.1216)


   

methanesulfonic acid 5-boc-amino-pentyl ester

methanesulfonic acid 5-boc-amino-pentyl ester

C11H23NO5S (281.1297)


   

(R)-(+)-4-Isopropyl-5,5-diphenyl-2-oxazolidinone

(R)-(+)-4-Isopropyl-5,5-diphenyl-2-oxazolidinone

C18H19NO2 (281.1416)


   

4-o-pivaloyl-3-hydroxy-l-phenylalanine

4-o-pivaloyl-3-hydroxy-l-phenylalanine

C14H19NO5 (281.1263)


   

1-(4-METHYLPHENYL)-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE

1-(4-METHYLPHENYL)-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE

C18H19NO2 (281.1416)


   

Boc-(R)-2-Methoxy-phenylglycine

Boc-(R)-2-Methoxy-phenylglycine

C14H19NO5 (281.1263)


   

3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl) cyclopropyl]oxy]carbonyl]-L-Valine

3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl) cyclopropyl]oxy]carbonyl]-L-Valine

C15H23NO4 (281.1627)


   

(S,S)-2-Azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride

(S,S)-2-Azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride

C15H20ClNO2 (281.1182)


   

METHYL BETA-NEURAMINIC ACID

METHYL BETA-NEURAMINIC ACID

C10H19NO8 (281.1111)


   

pp1

1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C16H19N5 (281.164)


   
   

TERT-BUTYL 5-(2-CHLOROETHYL)INDOLINE-1-CARBOXYLATE

TERT-BUTYL 5-(2-CHLOROETHYL)INDOLINE-1-CARBOXYLATE

C15H20ClNO2 (281.1182)


   

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H20BNO2 (281.1587)


   

6-(4-aminophenyl)-4-ethoxypyrido[3,2-d]pyrimidin-2-amine

6-(4-aminophenyl)-4-ethoxypyrido[3,2-d]pyrimidin-2-amine

C15H15N5O (281.1277)


   

N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

C18H23N3 (281.1892)


   

(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-HYDROXYPHENYL)PROPANOIC ACID

(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-HYDROXYPHENYL)PROPANOIC ACID

C14H19NO5 (281.1263)


   

2-C-Methyladenosine

2-C-Methyladenosine

C11H15N5O4 (281.1124)


2'-C-Methyladenosine is an inhibitor of hepatitis C virus (HCV) replication. 2'-C-Methyladenosine inhibits HCV replicon and NS5B-catalyzed RNA synthesis with IC50 values of 0.3μM and 1.9 μM, respectively. 2'-C-Methyladenosine also potently inhibits LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis[1][2].

   

(4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER

(4-FLUOROPHENYLAMINO)METHYLENEMALONIC ACID DIETHYL ESTER

C14H16FNO4 (281.1063)


   

3,4-diphenylisoquinoline

3,4-diphenylisoquinoline

C21H15N (281.1204)


   
   

Benzenamine,N-[(4-butoxyphenyl)methylene]-4-ethyl-

Benzenamine,N-[(4-butoxyphenyl)methylene]-4-ethyl-

C19H23NO (281.178)


   
   

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   

boc-(s)-3-amino-3-(3-hydroxy-phenyl)-propionic acid

boc-(s)-3-amino-3-(3-hydroxy-phenyl)-propionic acid

C14H19NO5 (281.1263)


   

2-Chloro-1-(6-methoxy-2,2,4-trimethyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone

2-Chloro-1-(6-methoxy-2,2,4-trimethyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone

C15H20ClNO2 (281.1182)


   

3-[(2R)-1-acetyl-2-pyrrolidinyl]--aMino-5-isoxazolepropanoic acid Methyl ester

3-[(2R)-1-acetyl-2-pyrrolidinyl]--aMino-5-isoxazolepropanoic acid Methyl ester

C13H19N3O4 (281.1375)


   

1H-Imidazolium, 1-decyl-3-methyl-, thiocyanate

1H-Imidazolium, 1-decyl-3-methyl-, thiocyanate

C15H27N3S (281.1926)


   

2-Benzyl-2,3-dihydro-1H-isoindole-1-carboxylic acid ethyl ester

2-Benzyl-2,3-dihydro-1H-isoindole-1-carboxylic acid ethyl ester

C18H19NO2 (281.1416)


   

N-(L-ALANYL)-2-AMINOACRIDONE FOR FLUORE

N-(L-ALANYL)-2-AMINOACRIDONE FOR FLUORE

C16H15N3O2 (281.1164)


   

4-((2,2-dimethyl-1,3-dioxan-5-yl)methoxy)-2,3,5-trimethylpyridine1-oxide

4-((2,2-dimethyl-1,3-dioxan-5-yl)methoxy)-2,3,5-trimethylpyridine1-oxide

C15H23NO4 (281.1627)


   

ethyl 4-(cyclopentylamino)-2-methylsulfanylpyrimidine-5-carboxylate

ethyl 4-(cyclopentylamino)-2-methylsulfanylpyrimidine-5-carboxylate

C13H19N3O2S (281.1198)


   
   

tert-butyl N-[2-(2-nitroanilino)ethyl]carbamate

tert-butyl N-[2-(2-nitroanilino)ethyl]carbamate

C13H19N3O4 (281.1375)


   

Methyl 5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate

Methyl 5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate

C13H17BFNO4 (281.1235)


   

N-Benzyl-N-isopropyl-3,5-dimethylbenzamide

N-Benzyl-N-isopropyl-3,5-dimethylbenzamide

C19H23NO (281.178)


   

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

C17H19N3O (281.1528)


   

TRANS-1-BENZYL-4-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID

TRANS-1-BENZYL-4-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID

C18H19NO2 (281.1416)


   

3-amino-4-methoxy-9-phenyl-5,8,10-trioxabicyclo[4.4.0]decan-2-ol

3-amino-4-methoxy-9-phenyl-5,8,10-trioxabicyclo[4.4.0]decan-2-ol

C14H19NO5 (281.1263)


   

2-(4-Benzyl-piperazin-1-yl-methyl)aniline

2-(4-Benzyl-piperazin-1-yl-methyl)aniline

C18H23N3 (281.1892)


   

[2-[(tert-butoxycarbonyl)amino]-3-methoxyphenyl]acetic acid

[2-[(tert-butoxycarbonyl)amino]-3-methoxyphenyl]acetic acid

C14H19NO5 (281.1263)


   

3-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoic acid

3-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoic acid

C14H19NO5 (281.1263)


   

cladribine related compound a (20 mg) (2-methoxy-2-deoxyadenosine)

cladribine related compound a (20 mg) (2-methoxy-2-deoxyadenosine)

C11H15N5O4 (281.1124)


   

Boc-D-tyrosine

Boc-D-tyrosine

C14H19NO5 (281.1263)


   

5-tert-butyl-2-methyl-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

5-tert-butyl-2-methyl-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C15H23NO4 (281.1627)


   

3-Borono-5-((tert-butoxycarbonyl)amino)benzoic acid

3-Borono-5-((tert-butoxycarbonyl)amino)benzoic acid

C12H16BNO6 (281.1071)


   

2-(Adamantan-1-yl)isoindoline-1,3-dione

2-(Adamantan-1-yl)isoindoline-1,3-dione

C18H19NO2 (281.1416)


   

5-[(4-Methylpiperazin-1-yl)sulfonyl]indoline

5-[(4-Methylpiperazin-1-yl)sulfonyl]indoline

C13H19N3O2S (281.1198)


   

3-(Boc-amino)-3-(4-Methoxyphenyl)-1-propanol

3-(Boc-amino)-3-(4-Methoxyphenyl)-1-propanol

C15H23NO4 (281.1627)


   

Blarcamesine

Blarcamesine

C19H23NO (281.178)


C26170 - Protective Agent > C1509 - Neuroprotective Agent Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome[1].

   
   

Talsaclidine fumarate

Talsaclidine fumarate

C14H19NO5 (281.1263)


C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist

   

Tetrydamine maleate

Tetrydamine maleate

C13H19N3O4 (281.1375)


   

3-Methyladenosine

3-Methyladenosine

C11H15N5O4 (281.1124)


   

Mirtazapine N-Oxide

Mirtazapine N-Oxide

C17H19N3O (281.1528)


   

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

7-Phenyl-7-(3-pyridyl)-6-heptenoic acid

C18H19NO2 (281.1416)


D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

   

5-(2-Amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

5-(2-Amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C11H15N5O4 (281.1124)


   

2,3,3-Triphenylacrylonitrile

Benzeneacetonitrile, a-(diphenylmethylene)-

C21H15N (281.1204)


   

4-[(2R)-2-[(1R,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

4-[(2R)-2-[(1R,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

N-cyclooctyl-4-methylbenzenesulfonamide

N-cyclooctyl-4-methylbenzenesulfonamide

C15H23NO2S (281.1449)


   

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

C17H19N3O (281.1528)


   

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

C17H19N3O (281.1528)


   

6-Methylaminopurine arabinoside

6-Methylaminopurine arabinoside

C11H15N5O4 (281.1124)


   

3-Acetyl-5-hydroxy-4,5-dimethyl-1-octyl-2-pyrrolone

3-Acetyl-5-hydroxy-4,5-dimethyl-1-octyl-2-pyrrolone

C16H27NO3 (281.1991)


   

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

C17H19N3O (281.1528)


   

1-Piperidinecarboxylic acid (4-phenylphenyl) ester

1-Piperidinecarboxylic acid (4-phenylphenyl) ester

C18H19NO2 (281.1416)


   

N-[2-(3-pyridinyl)-1,3-benzoxazol-5-yl]butanamide

N-[2-(3-pyridinyl)-1,3-benzoxazol-5-yl]butanamide

C16H15N3O2 (281.1164)


   

4-(2-fluorophenyl)-N-(2-methylbut-3-yn-2-yl)benzamide

4-(2-fluorophenyl)-N-(2-methylbut-3-yn-2-yl)benzamide

C18H16FNO (281.1216)


   

8-Methyladenosine

8-Methyladenosine

C11H15N5O4 (281.1124)


   

3-(3,5-Dimethylanilino)-5-(2-furanyl)-1-cyclohex-2-enone

3-(3,5-Dimethylanilino)-5-(2-furanyl)-1-cyclohex-2-enone

C18H19NO2 (281.1416)


   

4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butanoic acid hydrochloride

4-[4-phenyl-3,6-dihydro-1(2H)-pyridinyl]butanoic acid hydrochloride

C15H20ClNO2 (281.1182)


   

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

C17H19N3O (281.1528)


   

O-Mannopyranosylthreonine

O-Mannopyranosylthreonine

C10H19NO8 (281.1111)


   

8-Hydroxymirtazapine, (R)-

8-Hydroxymirtazapine, (R)-

C17H19N3O (281.1528)


   

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

C17H19N3O (281.1528)


   

2-Hydroxymethyl-5-(7-methylamino-3H-pyrazolo[4,3-D]pyrimidin-3-YL)-tetrahydro-furan-3,4-diol

2-Hydroxymethyl-5-(7-methylamino-3H-pyrazolo[4,3-D]pyrimidin-3-YL)-tetrahydro-furan-3,4-diol

C11H15N5O4 (281.1124)


   

4-Imidazolmethylene-5-Imidazolone Chromophore

4-Imidazolmethylene-5-Imidazolone Chromophore

C11H15N5O4 (281.1124)


   

PENDIMETHALIN

PENDIMETHALIN

C13H19N3O4 (281.1375)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Pridopidine

Pridopidine

C15H23NO2S (281.1449)


C78272 - Agent Affecting Nervous System Pridopidine, a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist. Pridopidine exerts high affinity towards sigma 1 receptor (S1R) with Ki between 70 and 80 nM, which is ~100× higher than its affinity toward D2R.

   

LUFIRONIL

LUFIRONIL

C13H19N3O4 (281.1375)


C471 - Enzyme Inhibitor

   

3153-55-7

4H-Dibenzo(de,g)quinolin-2-ol, 5,6,6a,7-tetrahydro-1-methoxy-6-methyl-, (R)-

C18H19NO2 (281.1416)


   

2-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide

2-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide

C15H23NO4 (281.1627)


   

7-methylisodomoic acid A

7-methylisodomoic acid A

C15H23NO4 (281.1627)


   

N(6)-methylformycin A

N(6)-methylformycin A

C11H15N5O4 (281.1124)


   

dihydroxyphaseic acid

dihydroxyphaseic acid

C15H21O5- (281.1389)


   

N-[3-[(4-Aminobutyl)amino]propyl]-3,4-dihydroxybenzamide

N-[3-[(4-Aminobutyl)amino]propyl]-3,4-dihydroxybenzamide

C14H23N3O3 (281.1739)


   

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

(2S)-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

(Z)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid

(Z)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid

C18H19NO2 (281.1416)


D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

   

1-Propanamine, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-N-methyl-

1-Propanamine, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-N-methyl-

C18H19NS (281.1238)


   

(2E,4E)-5-(3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl)-3-methylpenta-2,4-dienoate

(2E,4E)-5-(3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl)-3-methylpenta-2,4-dienoate

C15H21O5- (281.1389)


   

Pisoniamide

Pisoniamide

C18H19NO2 (281.1416)


A member of the class of cinnamamides that is trans-cinnamamide substituted by a 2-(4-methoxyphenyl)ethyl group at the nitrogen atom. It has been isolated from Pisonia aculeata.

   

4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine

C16H15N3O2 (281.1164)


   

6-methylformycin A

6-methylformycin A

C11H15N5O4 (281.1124)


   

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

C16H24ClNO (281.1546)


   

8-(3-ethoxypropylamino)-1,3-dimethyl-7H-purine-2,6-dione

8-(3-ethoxypropylamino)-1,3-dimethyl-7H-purine-2,6-dione

C12H19N5O3 (281.1488)


   

2-(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-4,6-dimethyl-3-pyridinecarbonitrile

2-(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-4,6-dimethyl-3-pyridinecarbonitrile

C16H15N3O2 (281.1164)


   

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

C17H19N3O (281.1528)


   

N-[(E)-Furan-2-ylmethylideneamino]-8-methoxy-2-methylquinolin-4-amine

N-[(E)-Furan-2-ylmethylideneamino]-8-methoxy-2-methylquinolin-4-amine

C16H15N3O2 (281.1164)


   

N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)butanamide

N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)butanamide

C16H15N3O2 (281.1164)


   

6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-ethyl-1H-pyrimidine-2,4-dione

6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-ethyl-1H-pyrimidine-2,4-dione

C13H19N3O4 (281.1375)


   

4-(4-Chlorophenoxy)-1-(1-piperidinyl)-1-butanone

4-(4-Chlorophenoxy)-1-(1-piperidinyl)-1-butanone

C15H20ClNO2 (281.1182)


   

1-(1-Oxo-2-thiophen-2-ylethyl)-4-piperidinecarboxylic acid ethyl ester

1-(1-Oxo-2-thiophen-2-ylethyl)-4-piperidinecarboxylic acid ethyl ester

C14H19NO3S (281.1086)


   

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

C17H19N3O (281.1528)


   

5-(3-Phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

5-(3-Phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole

C16H15N3O2 (281.1164)


   

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

C17H19N3O (281.1528)


   

3-[2-(3-Phenoxypropyl)-5-tetrazolyl]pyridine

3-[2-(3-Phenoxypropyl)-5-tetrazolyl]pyridine

C15H15N5O (281.1277)


   

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

C17H19N3O (281.1528)


   

(E)-1-[2-(Hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

(E)-1-[2-(Hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

1-Ethyl-2-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3-indole]one

1-Ethyl-2-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3-indole]one

C16H15N3O2 (281.1164)


   

4-[[[2-(Isopropyloxy)phenoxy]carbonyl]amino]butanoic acid

4-[[[2-(Isopropyloxy)phenoxy]carbonyl]amino]butanoic acid

C14H19NO5 (281.1263)


   

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

Ibogamine(1+)

Ibogamine(1+)

C19H25N2+ (281.2018)


A tertiary ammonium ion resulting from the protonation of the tertiary amino group of ibogamine. It is the major microspecies at pH 7.3.

   

fumisoquin A cation

fumisoquin A cation

C13H17N2O5+ (281.1137)


   

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

C13H21N4O3+ (281.1614)


   

N1-Methyl-2-deoxyguanosine

N1-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


   

(11bS)-11b-methyl-3,4,6,7,11b,12-hexahydro-1H-isoquino[2,1-a]quinoline-1,13(2H)-dione

(11bS)-11b-methyl-3,4,6,7,11b,12-hexahydro-1H-isoquino[2,1-a]quinoline-1,13(2H)-dione

C18H19NO2 (281.1416)


   

D-Gluconic acid, 6-ester with N,N-dimethylglycine

D-Gluconic acid, 6-ester with N,N-dimethylglycine

C10H19NO8 (281.1111)


   

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]acetamide

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]acetamide

C16H27NO3 (281.1991)


   

6-Methyl-4-(N,N-dimethylamino)flavanone

6-Methyl-4-(N,N-dimethylamino)flavanone

C18H19NO2 (281.1416)


   

4-(3-(4-(2-Hydroxyethoxy)phenoxy)propyl)morphorine

4-(3-(4-(2-Hydroxyethoxy)phenoxy)propyl)morphorine

C15H23NO4 (281.1627)


   

N-[1-(1-Naphthyl)ethyl]-2,3-dimethyl-4-pentenamide

N-[1-(1-Naphthyl)ethyl]-2,3-dimethyl-4-pentenamide

C19H23NO (281.178)


   

2-Amino-4,8-bis(methoxymethyl)azulene-1,3-dicarbonitrile

2-Amino-4,8-bis(methoxymethyl)azulene-1,3-dicarbonitrile

C16H15N3O2 (281.1164)


   

2-(3-Hydroxybutoxy)-N-(2-(ethylamino)ethyl)-3-pyridinecarboxamide

2-(3-Hydroxybutoxy)-N-(2-(ethylamino)ethyl)-3-pyridinecarboxamide

C14H23N3O3 (281.1739)


   

3-(carboxymethyl)-4-[(2E)-6-methylhepta-2,5-dien-2-yl]pyrrolidine-2-carboxylic acid

3-(carboxymethyl)-4-[(2E)-6-methylhepta-2,5-dien-2-yl]pyrrolidine-2-carboxylic acid

C15H23NO4 (281.1627)


   

DIMINAZENE

DIMINAZENE

C14H15N7 (281.1389)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

O(6)-Methyl-2-deoxyguanosine

O(6)-Methyl-2-deoxyguanosine

C11H15N5O4 (281.1124)


O6-Methyldeoxy guanosine; DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

C15H23NO4 (281.1627)


   

(E)-2-Hydroxy-N-desmethyldoxepin

(E)-2-Hydroxy-N-desmethyldoxepin

C18H19NO2 (281.1416)


   

N-(1-Deoxy-1-fructosyl)threonine

N-(1-Deoxy-1-fructosyl)threonine

C10H19NO8 (281.1111)


   

fumisoquin A(1+)

fumisoquin A(1+)

C13H17N2O5 (281.1137)


A primary ammonium ion that is the conjugate acid of fumisoquin A, obtained from the protonation of the amino group. Major microspecies at pH 7.3.

   

cordysinin B

cordysinin B

C11H15N5O4 (281.1124)


A member of the class of adenosines that is adenosine in which the hydroxy group at position 2 is replaced by a methoxy group. It has been isolated from the mycelia of Cordyceps sinensis.

   
   
   

Methyladenosine

Methyladenosine

C11H15N5O4 (281.1124)


   

O-Methyladenosine

O-Methyladenosine

C11H15N5O4 (281.1124)


   

2’-Deoxy-N1-methylguanosine

2’-Deoxy-N1-methylguanosine

C11H15N5O4 (281.1124)


2’-Deoxy-N1-methylguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

PPARα/γ agonist 1

PPARα/γ agonist 1

C18H19NO2 (281.1416)


PPARα/γ agonist 1 is a potent and dual PPARα/γ partial agonist with EC50 values of 28 nM and 69 nM for PPARα and PPARγ, respectively. PPARα/γ agonist 1 is a promising prototype for dyslipidemia and diabetes research[1].

   

(1r,5s,16s)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,5s,16s)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

(2e,4e,12z)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

(2e,4e,12z)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)


   

(2e,7e,9e)-6,11-dihydroxy-n-(2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,7e,9e)-6,11-dihydroxy-n-(2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO3 (281.1991)


   

2-[(3z)-hex-3-en-1-yl]-1h,2h,3h,4h-pyrido[1,2-a]quinolin-6-one

2-[(3z)-hex-3-en-1-yl]-1h,2h,3h,4h-pyrido[1,2-a]quinolin-6-one

C19H23NO (281.178)


   

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol

C11H15N5O4 (281.1124)


   

(9s)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

(9s)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(methoxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(methoxymethyl)oxolane-3,4-diol

C11H15N5O4 (281.1124)


   

5,11-dihydroxy-9-methoxy-8-methyl-2-[(1z)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

5,11-dihydroxy-9-methoxy-8-methyl-2-[(1z)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

2,4-dihydroxy-n-[(2s)-1-methoxy-1-oxopropan-2-yl]-3,5,6-trimethylbenzenecarboximidic acid

2,4-dihydroxy-n-[(2s)-1-methoxy-1-oxopropan-2-yl]-3,5,6-trimethylbenzenecarboximidic acid

C14H19NO5 (281.1263)


   

2-[(4e,6z)-3-oxonona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(4e,6z)-3-oxonona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H19NO2 (281.1416)


   

(3s)-5-[(1e,3s,5s)-3,5-dimethyl-2-oxocyclohexylidene]-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

(3s)-5-[(1e,3s,5s)-3,5-dimethyl-2-oxocyclohexylidene]-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

C15H23NO4 (281.1627)


   

5'-o-methyladenosine

NA

C11H15N5O4 (281.1124)


{"Ingredient_id": "HBIN011859","Ingredient_name": "5'-o-methyladenosine","Alias": "NA","Ingredient_formula": "C11H15N5O4","Ingredient_Smile": "COCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O","Ingredient_weight": "281.27 g/mol","OB_score": "22.44657067","CAS_id": "NA","SymMap_id": "SMIT08694","TCMID_id": "NA","TCMSP_id": "MOL007215","TCM_ID_id": "NA","PubChem_id": "6480505","DrugBank_id": "NA"}

   

acetyllycofawcine

NA

C16H27NO3 (281.1991)


{"Ingredient_id": "HBIN014481","Ingredient_name": "acetyllycofawcine","Alias": "NA","Ingredient_formula": "C16H27NO3","Ingredient_Smile": "CC1CC23C4CCCN2CCCC3(C(C1O)CC4O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33364","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β- glucosidase

NA

C10H19NO8 (281.1111)


{"Ingredient_id": "HBIN018132","Ingredient_name": "\u03b2- glucosidase","Alias": "NA","Ingredient_formula": "C10H19NO8","Ingredient_Smile": "C(C1C(C(C(C(O1)OCC(CO)NC=O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38177","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

diphenylmethyl 3,3-dimethylaziridine-2-carboxylate

diphenylmethyl 3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

(9r)-5-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

(9r)-5-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

C18H19NO2 (281.1416)


   

(1r,2s,7as)-1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

(1r,2s,7as)-1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

C16H27NO3 (281.1991)


   

3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazole-2,6-diol

3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazole-2,6-diol

C18H19NO2 (281.1416)


   

diphenylmethyl (2s)-3,3-dimethylaziridine-2-carboxylate

diphenylmethyl (2s)-3,3-dimethylaziridine-2-carboxylate

C18H19NO2 (281.1416)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]propanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]propanamide

C13H19N3O4 (281.1375)


   

(2r,6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

(2r,6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

(1s,2s)-1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

(1s,2s)-1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

C11H15N5O4 (281.1124)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]ethanimidic acid

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

6-methyl-1-(3-methylbut-2-en-1-yl)-9h-carbazole-2,7-diol

6-methyl-1-(3-methylbut-2-en-1-yl)-9h-carbazole-2,7-diol

C18H19NO2 (281.1416)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}propanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}propanamide

C13H19N3O4 (281.1375)


   

5-(3,5-dimethyl-2-oxocyclohexylidene)-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

5-(3,5-dimethyl-2-oxocyclohexylidene)-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

C15H23NO4 (281.1627)


   

2-[(2r,4s)-2-[(3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

2-[(2r,4s)-2-[(3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

(12bs)-10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

(12bs)-10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C18H19NO2 (281.1416)


   

n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

C18H19NO2 (281.1416)


   

1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

1-[2-(dimethylamino)-4-hydroxypteridin-6-yl]propane-1,2,3-triol

C11H15N5O4 (281.1124)


   

(6s,8as,9s,11s,12ar)-4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

(6s,8as,9s,11s,12ar)-4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

C15H23NO4 (281.1627)


   

(4r,5r,6r,9r,10r)-4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

(4r,5r,6r,9r,10r)-4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

(9s)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

(9s)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C18H19NO2 (281.1416)


   

15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

2-[(2r,4s)-2-[(1s,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

2-[(2r,4s)-2-[(1s,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

C15H23NO4 (281.1627)


   

(2e,4e,9e)-8,11-dihydroxy-n-(2-methylpropyl)dodeca-2,4,9-trienimidic acid

(2e,4e,9e)-8,11-dihydroxy-n-(2-methylpropyl)dodeca-2,4,9-trienimidic acid

C16H27NO3 (281.1991)


   

2,4-dihydroxy-n-(1-methoxy-1-oxopropan-2-yl)-3,5,6-trimethylbenzenecarboximidic acid

2,4-dihydroxy-n-(1-methoxy-1-oxopropan-2-yl)-3,5,6-trimethylbenzenecarboximidic acid

C14H19NO5 (281.1263)


   

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1h-quinolin-4-one

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1h-quinolin-4-one

C19H23NO (281.178)


   

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

n-(4-{9h-pyrido[3,4-b]indol-1-yl}butyl)guanidine

n-(4-{9h-pyrido[3,4-b]indol-1-yl}butyl)guanidine

C16H19N5 (281.164)


   

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enimidic acid

C18H19NO2 (281.1416)


   

5,11-dihydroxy-9-methoxy-8-methyl-2-(prop-1-en-1-yl)-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

5,11-dihydroxy-9-methoxy-8-methyl-2-(prop-1-en-1-yl)-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

(2e,6e,8e)-10-hydroxy-n-(2-hydroxy-2-methylpropyl)-5-oxoundeca-2,6,8-trienimidic acid

(2e,6e,8e)-10-hydroxy-n-(2-hydroxy-2-methylpropyl)-5-oxoundeca-2,6,8-trienimidic acid

C15H23NO4 (281.1627)


   

(2r,8e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

(2r,8e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

4-[(2r)-2-[(1r,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1r,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

(6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

(6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

(1s,2s,5s,6s,8s,11s)-5,11-dihydroxy-9-methoxy-8-methyl-2-[(1e)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

(1s,2s,5s,6s,8s,11s)-5,11-dihydroxy-9-methoxy-8-methyl-2-[(1e)-prop-1-en-1-yl]-7-oxa-9-azatricyclo[6.2.1.0¹,⁶]undec-3-en-10-one

C14H19NO5 (281.1263)


   

(9s)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

(9s)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

(2r,4e)-1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2-methylhex-4-en-1-one

(2r,4e)-1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2-methylhex-4-en-1-one

C14H19NO5 (281.1263)


   

2-(3,7-dimethylocta-2,6-dien-1-yl)-1h-quinolin-4-one

2-(3,7-dimethylocta-2,6-dien-1-yl)-1h-quinolin-4-one

C19H23NO (281.178)


   

(9r)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

(9r)-15-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C18H19NO2 (281.1416)


   

(1r,3s,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1r,3s,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C15H23NO4 (281.1627)


   

1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

C16H27NO3 (281.1991)


   

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

4-[(2r)-2-[(1s,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1s,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

4-[(2r)-2-[(1r,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1r,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

(2e,4e,6e,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6e,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C19H23NO (281.178)


   

(2e,4e,12e)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

(2e,4e,12e)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)


   

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C18H19NO2 (281.1416)


   

(1r,5s,16r)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,5s,16r)-5-hydroxy-5-methyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C14H19NO5 (281.1263)


   

10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

10-methoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C18H19NO2 (281.1416)


   

(2e,4e,6z,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6z,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C19H23NO (281.178)


   

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-(prop-1-en-1-yl)-2-azaspiro[4.5]dec-7-en-1-one

4,9,10-trihydroxy-2-methoxy-3-methylidene-6-(prop-1-en-1-yl)-2-azaspiro[4.5]dec-7-en-1-one

C14H19NO5 (281.1263)


   

3-hydroxy-2,6,8-trimethyl-4a-(2-oxopropyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione

3-hydroxy-2,6,8-trimethyl-4a-(2-oxopropyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione

C11H15N5O4 (281.1124)


   

(9r)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

(9r)-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol

C18H19NO2 (281.1416)


   

(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C18H19NO2 (281.1416)


   

1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)